Newsfeeds Archive - Spark Newswire

1 minute read

Milestone Pharmaceuticals To Present Data On Etripamil At The Preventative Cardiovascular Nursing Symposium

April 17, 8:12 AM

Milestone® Pharmaceuticals Inc. (NASDAQ:MIST) a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that it will present data on

MIST

2 minute read

Milestone Pharmaceuticals Announces Etripamil Data Demonstrating Patients’ Ability To Self-Manage Recurring PSVT, Presented At The American College Of Cardiology Annual Meeting

By Benzinga Newsdesk

April 8, 11:37 AM

MIST

1 minute read

Milestone Pharmaceuticals To Present Data On Etripamil At The American College Of Cardiology And European Heart Rhythm Association Annual Conferences

By Benzinga Newsdesk

April 1, 8:02 AM

MIST

2 minute read

Top 5 Health Care Stocks That Could Lead To Your Biggest Gains in January

By Avi Kapoor

January 2, 8:06 AM

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

CORT

2 minute read

Meta To Rally Over 18%? Here Are 10 Top Analyst Forecasts For Wednesday

By Avi Kapoor

December 27, 10:06 AM

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

ASPN

2 minute read

Nasdaq Surges 75 Points; Inspira Technologies Shares Spike Higher

By Avi Kapoor

December 26, 3:43 PM

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 150 points on Tuesday. The Dow traded up 0.50% to 37,574.66 while the NASDAQ rose 0.50% to 15,068.50. The S&P 500 also rose, gaining, 0.45% to 4,776.17.

AZN

4 minute read

Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session

By Avi Kapoor

December 26, 2:48 PM

Shares of RayzeBio, Inc. (NASDAQ: RYZB) rose sharply during Tuesday’s session after the company announced that it will be acquired by Bristol Myers Squibb for $62.50 per share in cash in a deal worth $4.1 billion. RayzeBio shares gained 100% to $61.38 on Tuesday.

AAOI

1 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

December 26, 1:31 PM

Gainers RayzeBio (NASDAQ:RYZB) stock moved upwards by 100.8% to $61.4 during Tuesday’s regular session. The market value of…

BACK

2 minute read

Crude Oil Rises Over 3%; US Home Prices Increase In October

By Avi Kapoor

December 26, 1:20 PM

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 100 points on Tuesday. The Dow traded up 0.34% to 37,511.87 while the NASDAQ rose 0.43% to 15,057.13. The S&P 500 also rose, gaining, 0.34% to 4,770.79.

ADEX

1 minute read

Why Is Heart Disease-Focused Milestone Pharmaceuticals Stock Plummeting Today?

By Vandana Singh

December 26, 10:53 AM

Milestone Pharmaceuticals Inc (NASDAQ: MIST) announced Tuesday that the Company received a Refusal to File (RTF) letter from the FDA for the New Drug Application seeking approval for self-administered etripamil nasal spray for paroxysmal

MIST